Radiation after targeted therapy may keep skin cancer away
NCT ID NCT05561634
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is for people with advanced basal cell skin cancer that has completely disappeared after taking targeted pills (vismodegib or sonidegib). The problem is that the cancer often returns when the pills are stopped. Researchers want to see if giving a short course of radiation therapy to the original tumor area can prevent the cancer from coming back. About 82 adults will take part, and half will get radiation plus standard monitoring, while the other half will only be monitored.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BASAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Lille
RECRUITINGLille, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Botox before the knife: could a Pre-Surgery injection lead to Better-Looking scars?
- Could a lighter immunotherapy schedule keep advanced cancers in check?
- New skin patch could speed recovery after skin cancer removal
- AI reads skin lesions to predict cancer aggressiveness
- Lung cancer radiation: new study tracks breathing side effects
- Needle-Free light therapy shows promise for common skin cancer